Open versus minimally invasive cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC): Results from a multicenter retrospective study
M.C. Mir(Fundación Instituto Valenciano de Oncología), Andrea Minervini(Azienda Ospedaliero-Universitaria Careggi), Riccardo Bertolo(University of Verona), Tobias Maurer(Universität Hamburg), M. Albertsen(KU Leuven), Umberto Capitanio(Vita-Salute San Raffaele University), S. Zhang, Riccardo Campi(University of Florence), Riccardo Autorino(Rush University Medical Center), M. Kriegmair(Urologische Klinik München), Li Ma(University of Pittsburgh Medical Center), José Rubio(Fundación Instituto Valenciano de Oncología), Georgi Guruli(VCU Massey Comprehensive Cancer Center), Siska Van Bruwaene(AZ Groeninge), Mireía Musquera(Surgical Specialties (Canada)), Alessandro Antonelli(University of Verona), Nicola Pavan(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Francesco Claps(University of Trieste), E. Rousel(University of California San Diego), F. Porpiglia(Ospedale San Luigi Gonzaga), Vital Hevia(Hospital Universitario Ramón y Cajal), Ithaar Derweesh(Rush University Medical Center), Tobias Klatte(Helios Hospital Bad Saarow)
Cited by 0
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386
Supine Valdivia and modified lithotomy position for simultaneous anterograde and retrograde endourological access
|British Journal of Urology|2007|288
Urology practice during the COVID-19 pandemic
|Minerva Urologica e Nefrologica|2020|256
NIFEDIPINE VERSUS TAMSULOSIN FOR THE MANAGEMENT OF LOWER URETERAL STONES
|The Journal of Urology|2004|242